Entity Common Stock, Shares Outstanding of SAB Biotherapeutics, Inc. from 29 Mar 2021 to 02 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
SAB Biotherapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 29 Mar 2021 to 02 Mar 2026.
  • SAB Biotherapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 02 Mar 2026 was 50,951,037, a 449% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

SAB Biotherapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 50,951,037 +41,662,169 +449% 02 Mar 2026 10-K 09 Mar 2026 2025 FY
Q3 2025 47,606,851 +38,377,577 +416% 10 Nov 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 10,411,061 +1,181,787 +13% 01 Aug 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 9,288,868 +63,374 +0.69% 21 Mar 2025 10-K 31 Mar 2025 2024 FY
Q3 2024 9,229,274 -43,089,882 -82% 01 Nov 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 9,229,274 -43,089,882 -82% 02 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 9,225,494 -41,172,268 -82% 18 Mar 2024 10-K 29 Mar 2024 2023 FY
Q3 2023 52,319,156 +9,288,271 +22% 31 Oct 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 52,319,156 +9,288,271 +22% 31 Jul 2023 10-Q 21 Aug 2023 2023 Q2
Q1 2023 50,397,762 +7,442,641 +17% 28 Mar 2023 10-K/A 28 Apr 2023 2021 FY
Q3 2022 43,030,885 03 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 43,030,885 +28,238,685 +191% 29 Jul 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 42,955,121 +28,162,921 +190% 28 Mar 2022 10-K 29 Mar 2022 2021 FY
Q4 2021 43,474,779 15 Nov 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 14,792,200 09 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 14,792,200 29 Mar 2021 10-K 02 Apr 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.